GA
DVAX

Glenhill Advisors’s Dynavax Technologies DVAX Stock Holding History

Glenhill Advisors’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,801
Closed -$2.96M – 46
2016
Q4 		$2.96M Sell
3,801
-649
-15% -$4.75K 0.21% 39
2016
Q3 		$2.49M Buy
+4,450
New +$64K 0.15% 39

Other funds holding DVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Glenhill Advisors's DVAX Position: Q4 2017 in Review

Glenhill Advisors sold out of Dynavax Technologies (DVAX) in Q4 2017, closing a stake of 277,288 shares — an estimated $5.96M sold.

Glenhill Advisors first reported a position in DVAX in Q2 2015 and held it in 10 quarters. The position peaked at $22.5M in Q1 2016. 140 funds tracked by Wall St. Rank hold DVAX as of Q4 2017.

  • Glenhill Advisors reported no remaining Dynavax Technologies position as of Q4 2017 after selling out during the quarter.
  • Glenhill Advisors sold 277,288 Dynavax Technologies shares in Q4 2017, an estimated $5.96M.
  • Glenhill Advisors first reported a position in Dynavax Technologies in Q2 2015 and held it in 10 quarters.
  • Glenhill Advisors's Dynavax Technologies position peaked at $22.5M in Q1 2016.
  • 140 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2017.

Based on Glenhill Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.